MedTrace Logo

Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCC

NCT04920214 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-07-15

No results posted yet for this study

Summary

Currently, there are few studies on the diagnostic ability of CEUS-LI-RADS in patients with non-high risk factors for liver nodules. Whether this classification is applicable to such patients remains controversial. There are relatively few studies on the diagnostic efficacy of HCC in clinical diagnosis and the consistency between map readers, and the applicable population is only focused on patients with hepatic fibrosis. Therefore, this study explored the application value of CEUS Li-RADS in liver focal lesions in patients with non-high risk factors for hepatocellular carcinoma.

Conditions

Interventions

DIAGNOSTIC_TEST

SonoVue

CEUS examination was performed and corresponding image information of liver lesions was obtained.

Sponsors & Collaborators

  • Tianjin Third Central Hospital

    collaborator OTHER

  • Sichuan Provincial People's Hospital

    collaborator OTHER

  • Fujian Cancer Hospital

    collaborator OTHER_GOV

  • Jining First People's Hospital

    collaborator OTHER

  • General Hospital of Ningxia Medical University

    collaborator OTHER

  • Beijing Hospital

    collaborator OTHER_GOV

  • Red Cross Hospital, Hangzhou, China

    collaborator OTHER

  • Zhejiang Cancer Hospital

    collaborator OTHER

  • Shengjing Hospital

    collaborator OTHER

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Pintong Huang · Second Affiliated Hospital, School of Medicine, Zhejiang University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04920214 on ClinicalTrials.gov